https://www.inhibikase.com/investors/sec-filings/annual-reports/rss Inhibikase Therapeutics, Inc. (IKT) - Annual Reports en-us https://d1io3yog0oux5.cloudfront.net/inhibikase/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126371/0001193125-26-126371.pdf Thu, 26 Mar 26 16:33:25 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-126371/0001193125-26-126371.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-069236/0000950170-25-069236.pdf Mon, 12 May 25 16:21:53 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-069236/0000950170-25-069236.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-058693/0000950170-25-058693.pdf Fri, 25 Apr 25 16:07:20 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-058693/0000950170-25-058693.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-046096/0000950170-25-046096.pdf Thu, 27 Mar 25 16:20:40 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-25-046096/0000950170-25-046096.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-049174/0000950170-24-049174.pdf Fri, 26 Apr 24 16:21:06 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-049174/0000950170-24-049174.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-037160/0000950170-24-037160.pdf Wed, 27 Mar 24 16:06:59 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-24-037160/0000950170-24-037160.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-23-256998/0001193125-23-256998.pdf Mon, 16 Oct 23 17:24:37 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-23-256998/0001193125-23-256998.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-018359/0000950170-23-018359.pdf Fri, 05 May 23 16:36:23 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-018359/0000950170-23-018359.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-011133/0000950170-23-011133.pdf Fri, 31 Mar 23 07:14:08 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-23-011133/0000950170-23-011133.pdf https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-22-005203/0000950170-22-005203.pdf Thu, 31 Mar 22 16:21:17 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0000950170-22-005203/0000950170-22-005203.pdf